Kenneth R Shroyer

Title: Kenneth R. Shroyer: Innovator in Bladder Cancer Biomarkers

Introduction

Kenneth R. Shroyer is a notable inventor based in Setauket, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of bladder cancer. With a total of 3 patents, his work focuses on innovative methods for identifying biomarkers that can aid in early cancer detection.

Latest Patents

One of Kenneth R. Shroyer's latest patents is centered around Keratin 17 as a biomarker for bladder cancer. This patent provides methods for detecting and analyzing K17 expression in bladder samples obtained from subjects. The disclosure also includes methods and kits for identifying a mammalian subject with bladder cancer by detecting K17 expression in a sample. The present methods encompass both cell-based and cell-free techniques for determining the level of keratin 17 in samples collected from the bladder.

Career Highlights

Throughout his career, Kenneth has worked with esteemed institutions such as the State University of New York and Kdx Diagnostics, Inc. His expertise in the field has led to advancements in cancer diagnostics, making a significant impact on patient care.

Collaborations

Kenneth has collaborated with notable colleagues, including Luisa F. Escobar-Hoyos and Nam Hoon Kim. These partnerships have further enriched his research and development efforts in the medical field.

Conclusion

Kenneth R. Shroyer stands out as an innovator in the realm of bladder cancer diagnostics. His contributions through patents and collaborations continue to advance the understanding and detection of this critical disease.